Insider buys and sells (Form 4)

Oncotelic Therapeutics, Inc. insiders: buys and sells · OTLC

Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-10-28 and 2026-10-29. All filings on SEC EDGAR →

Bought
$23,537
Sold
$0
Buys
2
Sells
0

The 2 transactions

DateWhoRoleTransaction SharesPriceAmount
2026-10-29Trieu Vuong CHAIRMAN AND CEO buy 1.044.990 0,017 $17,765
2026-10-28Trieu Vuong CHAIRMAN AND CEO buy 312.000 0,0185 $5,772

How to read these transactions

There are 2 filed transactions for Oncotelic Therapeutics, Inc. (OTLC) between 2026-10-28 and 2026-10-29. All of them are by the same person. Open-market buys: 2, for $23,537. Sells: 0, for $0.

Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.

Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.

Other companies with insider trades

Oak Valley Bancorp (OVLY) · OBOOK HOLDINGS INC. (OWLS) · OXFORD INDUSTRIES INC (OXM) · Everpure, Inc. (P) · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) · PACS Group, Inc. (PACS) · PagSeguro Digital Ltd. (PAGS) · Pampa Energy Inc. (PAM)

Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.

Follow them next to your own portfolio

In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.

Create a free account